Home The Word Brain	My Amedeo FAQ Privacy About
	C49 In our changing world, speaking just English isn't enough. Open new doors with skills in another world language. Start with 7 words a day. Next week: +49.

Malignant Melanoma

Free Subscription 04.05.2025 1 Am J Dermatopathol 3 Ann Surg Oncol 2 Anticancer Res 1 BMC Cancer 1 Br J Cancer 2 Cancer 2 Cancer Res 1 Int J Cancer 2 J Am Acad Dermatol 3 J Clin Invest 1 Melanoma Res 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Dermatopathol

1. VAVRUKH P, LeBlanc RE, Yan S
   Diagnostic Utility of Preferentially Expressed Antigen in Melanoma (PRAME) and p16 Immunohistochemistry in Distinguishing Genital Melanomas From Benign Melanocytic Proliferations.
   Am J Dermatopathol. 2025 Apr 22. doi: 10.1097/DAD.0000000000002977.
   PubMed         Abstract available
   
   

   
   Ann Surg Oncol

2. PENNINGTON TE, Thompson JF, Saw RPM, Coker DJ, et al
   The Value of Sentinel Node Biopsy in Patients With Higher-Risk (T3, T4) Primary Cutaneous Melanomas: Insights Provided by a Stage II Risk Calculator.
   Ann Surg Oncol. 2025 May 2. doi: 10.1245/s10434-024-16699.
   PubMed        
   
   
3. NOVIS E, Tan J, Vignati D, Wong T, et al
   Cartilage Resection in the Surgical Management of Ear Melanoma.
   Ann Surg Oncol. 2025 Apr 28. doi: 10.1245/s10434-025-17294.
   PubMed         Abstract available
   
   
4. DUGAN MM, Beekman KE, DePalo DK, Parker LM, et al
   The Use of Radar-Guided Localization to Identify Metastatic Melanoma After Neoadjuvant Immunotherapy.
   Ann Surg Oncol. 2025 Apr 25. doi: 10.1245/s10434-025-17330.
   PubMed         Abstract available
   
   

   
   Anticancer Res

5. YOSHIKAWA N, Ikushima C, Tanaka N, Iwata E, et al
   Role of Platelet Interactions in Promoting Melanoma Malignancy With Insights into Proliferation, Cyclin D1 Expression, and Migration.
   Anticancer Res. 2025;45:1927-1934.
   PubMed         Abstract available
   
   
6. DICKE J, Hero L, Kuhl S, Goldbrunner R, et al
   Expression of YAP1 and TAZ in Melanoma-, Bronchial- and Breast Carcinoma Brain Metastasis: Primary vs. Relapsed Tumors.
   Anticancer Res. 2025;45:1807-1812.
   PubMed         Abstract available
   
   

   
   BMC Cancer

7. CHEN SH, Yu BY, Kuo WY, Lin YB, et al
   Unveiling the immune microenvironment of complex tissues and tumors in transcriptomics through a deconvolution approach.
   BMC Cancer. 2025;25.
   PubMed         Abstract available
   
   

   
   Br J Cancer

8. VAN DIJK EJ, Nienhuis HH, van den Eertwegh AJM, Boers-Sonderen MJ, et al
   Rechallenge of ipilimumab and nivolumab in advanced melanoma patients after previous ipilimumab-based therapy.
   Br J Cancer. 2025 Apr 29. doi: 10.1038/s41416-025-03027.
   PubMed         Abstract available
   
   

   
   Cancer

9. CHEN MF, Postow MA
   Top advances of the year: Neoadjuvant immunotherapy in melanoma.
   Cancer. 2025;131:e35877.
   PubMed        
   
   
10. NIERENGARTEN MB
    Two-fold increased risk of melanoma in childhood cancer survivors.
    Cancer. 2025;131:e35828.
    PubMed        
    
    

    
    Cancer Res

11. GADAL S, Boyer JA, Roy SF, Outmezguine NA, et al
    Tumorigenesis Driven by BRAFV600E Requires Secondary Mutations That Overcome Its Feedback Inhibition of RAC1 and Migration.
    Cancer Res. 2025;85:1611-1627.
    PubMed         Abstract available
    
    
12. SRIVASTAVA J, Yadav VK, Jimenez RV, Phadatare PR, et al
    Blocking Nitrosylation Induces Immunogenic Cell Death by Sensitizing NRAS-Mutant Melanoma to MEK Inhibitors.
    Cancer Res. 2025 Apr 27. doi: 10.1158/0008-5472.CAN-24-0693.
    PubMed         Abstract available
    
    

    
    Int J Cancer

13. CHELLADURAI M, Sagi-Assif O, Ben-Menachem S, Meshel T, et al
    A heterodimer of hemoglobin identifies theranostic targets on brain-metastasizing melanoma cells.
    Int J Cancer. 2025 Apr 26. doi: 10.1002/ijc.35458.
    PubMed         Abstract available
    
    

    
    J Am Acad Dermatol

14. KASHERI E, Sa B, Kraft G, Vattigunta M, et al
    Mapping Melanoma Mortality Hot Spots: A Geographic Spatial Analysis of Socioeconomic and Provider Disparities.
    J Am Acad Dermatol. 2025 Apr 25:S0190-9622(25)00680.
    PubMed        
    
    
15. MAI JZ, Sargen MR, Linet MS, Ike E, et al
    Impact of personal sun sensitivity and UV radiation on the association between blistering sunburns and melanoma.
    J Am Acad Dermatol. 2025 Apr 25:S0190-9622(25)00683.
    PubMed        
    
    

    
    J Clin Invest

16. STAEGER R, Tastanova A, Ghosh A, Winkelbeiner N, et al
    Tebentafusp elicits on-target cutaneous immune responses driven by cytotoxic T-cells in uveal melanoma patients.
    J Clin Invest. 2025 Apr 29:e181464. doi: 10.1172/JCI181464.
    PubMed         Abstract available
    
    
17. TORRES ACOSTA MA, Gurkan JK, Liu Q, Mambetsariev N, et al
    AMPK is necessary for Treg functional adaptation to microenvironmental stress during malignancy and viral pneumonia.
    J Clin Invest. 2025;135:e179572.
    PubMed         Abstract available
    
    
18. HYUN H, Sun B, Yazdimamaghani M, Wielgus A, et al
    Tumor-specific surface marker-independent targeting of tumors through nanotechnology and bioorthogonal glycochemistry.
    J Clin Invest. 2025;135:e184964.
    PubMed         Abstract available
    
    

    
    Melanoma Res

19. CHAVERON M, Toulemonde E, Desmedt E, Boileau M, et al
    Resolution of diffuse cuticular melanosis under immunotherapy in a patient with metastatic melanoma.
    Melanoma Res. 2025;35:213-215.
    PubMed        
    
    

    
    PLoS One

20. 
    Expression of Concern: General sensitization of melanoma cells for TRAIL-induced apoptosis by the potassium channel inhibitor TRAM-34 depends on release of SMAC.
    PLoS One. 2025;20:e0323638.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Melanoma is free of charge.